Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2013-02-22)Premium Content

Johnson And Johnson (JNJ)

2013-05-17@19:41:12 ET
Parker Waichman LLP Responds to Johnson & Johnson's Decision to Discontinue Some of Its DePuy All-metal and Ceramic-on-metal Hip Implant Products (PRW)

2013-05-17@16:17:26 ET
DePuy Announces It Will Stop Selling Metal-On-Metal Hip Implants, Notes Rottenstein Law Group LLP (PRW)

2013-05-17@15:05:47 ET
Shares of Johnson & Johnson Rise to a New 52-Week High (F71)

2013-05-17@11:53:15 ET
TherapeuticsMD Elects Jules A. Musing to Board of Directors (ABW)

2013-05-17@08:00:00 ET
(PRN)

2013-05-17@07:22:51 ET
TherapeuticsMD names Jules A Musing to board (MTO)

2013-05-17@05:13:10 ET
Form 144: Filing to Sell 4929 Shares of Johnson & Johnson (JNJ) (VKR)

2013-05-17@03:58:47 ET
Market Maker Surveillance Report. APDN, SIRI, JNJ, FMCC, FNMA, USMV, Highest Net Sell Volume and Negative Price Friction For Thursday, May 16th 2013 (MTO)

2013-05-16@11:12:23 ET
Personal Injury Law Firm Releases Tylenol Infographic Detailing Alleged Side Effects Linked to the Drug (PRW)

2013-05-16@10:09:21 ET
Potential Johnson and Johnson (JNJ) Trade Targets 3.40% Return (FBM)

2013-05-16@09:32:27 ET
Australia Patent for 'Method and apparatus for facilitating release of an ophthalmic lens' Ceases (ABW)

2013-05-16@08:00:43 ET
Recent Study Shows That Canadians Require More Education on Sun Protection (INW)

2013-05-16@08:00:03 ET
TherapeuticsMD Elects Jules A. Musing to Board of Directors (BIZ)

2013-05-16@01:37:35 ET
Roche reportedly looks to shed blood glucose meters unit (MTN)

2013-05-15@16:00:01 ET
Relypsa Announces Appointment of John Orwin as Chief Executive Officer (BIZ)

2013-05-15@15:33:22 ET
Shares of Johnson & Johnson Have Risen Above Previous 52-Week High (F71)

2013-05-15@11:44:11 ET
DePuy ASR Lawsuit Update: DePuy Moves to Exclude Evidence of Recall in Federal Trial, Rottenstein Law Group LLP Reports (PRW)

2013-05-15@09:41:40 ET
Analyzing the Global CNS Market: 2013 Edition (MTO)

2013-05-15@09:30:46 ET
The Hepatitis C Market Forecast to 2022 - Revolutionary Interferon-Free Regimens Arrive (MTO)

2013-05-15@08:01:24 ET
StockCall Scrutinizes PFE, MRK, JNJ, ABBV, and ZGNX (BSR)